Genetic testing for a cancer risk gene can literally be a lifesaver, helping more and more men, women and children sidestep diagnosis and disease by turning to preventive measures like surgeries, medi...

A blood test correctly identified 87% of stage 1 and 2 pancreatic cancers, according to a study published Sept. 16 in Nature Medicine. For the study, researchers from Duarte, Calif.-based City of Hope...

RAHWAY, N.J., and NUTLEY, N.J., Sept. 25, 2026 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eisai today announced the U.S. Food and Drug Administration (FDA) has appr...

By Benjamin Lowentritt, MD  | When a patient learns they have metastatic castration-sensitive prostate cancer (mCSPC), it often marks the beginning of a long and uncertain journey. The first conversat...

A new jab extended the length of time patients were cancer free, but it is unclear for how long.

Result in high-risk patients validates decades of research into mRNA-based therapeutic cancer vaccines.